Andre Larochelle, MD, PhD
Institution
National Institutes of Health - National Heart, Lung, and Blood Institute
Physician Status
accepting new patients
treatment
Jill de Jong, MD, PhD
Institution
University of Chicago Medicine, Comer Children's Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
Mahasweta Gooptu, MD
Institution
Dana-Farber cancer Institute
About
Dr. Gooptu attended medical school at Kolkata Medical College in India, followed by a residency at Albert Einstein Medical College and fellowship at Thomas Jefferson University. She completed an advanced fellowship in adult hematopoietic stem cell transplantation at Dana-Farber Cancer Institute and is currently an attending physician in the adult SCT division. Dr. Gooptu's research interests include post-transplantation immune reconstitution, haploidentical transplantation and autologous transplantation for severe autoimmune disorders.
Yazan F. Madanat, MD
Institution
UT Southwestern Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Yazan Madanat, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. Dr. Madanat earned his medical degree at the University of Jordan. He completed his residency training in internal medicine at the Cleveland Clinic and then received advanced training in hematology and medical oncology through a fellowship at the Cleveland Clinic Taussig Cancer Institute. Certified by the American Board of Internal Medicine, he joined the UT Southwestern leukemia and hematopoietic cell transplant program in the Division of Hematology and Oncology in 2019. Dr
Kohei Hosokawa, MD, PhD
Institution
Kanazawa University Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pedro Prata, MD, PhD
Institution
Centre Hospitalier Universitaire à Limoges
Physician Status
accepting new patients
Primary Disease Area of Focus
Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease
Original Publication Date
Article Source
External Web Content
Abstract Over the past 10 years, there has been a marked increase in recognition of the interplay between the intestinal microbiome and the hematopoietic system. Despite their apparent distance in the body, a large literature now supports the relevance of the normal intestinal…
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
Original Publication Date
Article Source
External Web Content
Key Points SCT from MUD offers superior survival outcomes for severe aplastic anemia compared to both MMUD and Haplo. The decision between a MMUD or Haplo donor in the absence of an available MUD remains uncertain. Selecting the most suitable alternative donor becomes challenging…
Trends in Volumes and Survival After Hematopoietic Cell Transplantation in Racial/Ethnic Minorities
Original Publication Date
Article Source
External Web Content
Key Points The number of autoHCT and alloHCT grew faster in Non-Hispanic African Americans and Hispanics compared to Non-Hispanic Whites. Survival after autoHCT and alloHCT improved over time for all racial/ ethnic groups, though African Americans have worse outcomes. There has…
PNH and Non-Transplant Therapies - 2023 New Haven Patient and Family Conference
Topic(s)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Dr. Nicolai Podoltsev describes options available for patients with PNH who could choose non-transplant treatments.